Advantages – performance measure [Two-Stage / GS Designs]

posted by d_labes  – Berlin, Germany, 2015-06-05 13:21 (3579 d 03:06 ago) – Posting: # 14917
Views: 19,504

Dear ElMaestro!

❝ We really need some kind of summary statistic that is the ultimate indicator of whether one method is better than the other. ...


Really good point!

Have a look into
Kieser, Rauch
"Two-stage designs for cross-over bioequivalence trials"
Stat Med 2015
DOI: 10.1002/sim.6487

They cite and use a performance score according to
Liu et al.
"Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval"
Stat Med 2008; 27:584–596.

But don't ask me for details! I haven't had a look into the last reference up to now :lookaround:.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
12 visitors (0 registered, 12 guests [including 1 identified bots]).
Forum time: 15:28 CET (Europe/Vienna)

An expert is one who knows more and more
about less and less.    Nicholas Murray Butler

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5